fk 3311 has been researched along with Disease Models, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwazaki, S; Kawashima, Y; Kawata, K; Matsumoto, K; Morishita, Y; Ohwada, S; Sunose, Y; Takeyoshi, I; Tomizawa, N; Tsutsumi, H | 1 |
1 other study(ies) available for fk 3311 and Disease Models, Animal
Article | Year |
---|---|
The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model.
Topics: 6-Ketoprostaglandin F1 alpha; Alanine Transaminase; Analysis of Variance; Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2; Disease Models, Animal; Dogs; Enzyme Inhibitors; Hyaluronic Acid; Isoenzymes; L-Lactate Dehydrogenase; Leukocyte Count; Liver; Liver Circulation; Neutrophils; Prostaglandin-Endoperoxide Synthases; Random Allocation; Reperfusion Injury; Thromboxane B2 | 2001 |